Ownership

Christopher Gibson - Chief Executive Officer, Director at Recursion Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: Chief Executive Officer, Director
Stock Symbol: RXRX on Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
All Insider Reports: All Insider Reports

Christopher Gibson - trading volume in the past year for Recursion Pharmaceuticals, Inc.

	Shares	%	Avg Price	Total $
Buys
Sells	-890K	100%	$8.45	-$7.52M
Net	-890K	-100%		-$7.52M

Holdings reported by Christopher Gibson for Recursion Pharmaceuticals, Inc.

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Class A Common Stock	737K	$4.55M	$6.18	Nov 15, 2024	Direct
Class B Common Stock	6.06M			Nov 15, 2024	Direct	Class A Common Stock	0
Stock Option (Right to Buy)	667K			Nov 15, 2024	Direct	Class A Common Stock	0
Class B Common Stock	486K			Nov 15, 2024	by LAHWRAN-3 LLC	Class A Common Stock	0
Class B Common Stock	388K			Nov 15, 2024	by LAHWRAN-4 LLC	Class A Common Stock	0
Class B Common Stock	67.9K			Nov 15, 2024	by Gibson Family Trust	Class A Common Stock	0

Transactions reported by Christopher Gibson for Recursion Pharmaceuticals, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.